Saturday, October 3, 2026

Search
HomeHealth NewsAntibody targeting CD38 enzyme shows positive impact in treating systemic sclerosis
Health News

Antibody targeting CD38 enzyme shows positive impact in treating systemic sclerosis

0
8
- Advertisement -

Elevated expression of NAD+-consuming enzymes in fibrotic skin. Credit: Scientific Reports (2023). DOI: 10.1038/s41598-023-49450-1

Scleroderma is a chronic autoimmune disease of women. Over time, people living with scleroderma develop progressive and irreversible scarring. Scarring, called fibrosis, affects the lungs, heart and kidneys,…

Click here to view the original article.

- Advertisment -
Previous article
New molecular sensor enables fluorescence imaging for assessing sarcoma severity
Next article
Fremantle singer Noah Dillon on new music, Soft tour and being a music therapist

RELATED ARTICLES

- Advertisement -

Recently Viewed

Load more

FEATURED

POPULAR POSTS

POPULAR CATEGORY

The Australian Online News Network acknowledges the traditional custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.

FOLLOW US

© 2024 Australian Online News | Privacy Policy